Novartis drug “Jakavi” has been approved by the European Commission for the therapy of rare blood cancer, polycythemia vera. It is the first approved targeted drug for treatment of this disease and it gives hope for patients unresponsive to standard therapy with hydroxyurea....
Read more
Horizon 2020 programme is the biggest financial instrument created by European Union (EU), which is aimed to support research and innovation development. With almost €80 billion funding that can be invested during years 2014-2020, the programme should help in keeping European economies competitive on...
Read more